{"id":"W3092112220","doi":"10.1016/j.jchf.2020.08.008","title":"N-Terminal Pro-B-Type Natriuretic Peptide and Clinical Outcomes","year":2020,"lang":"en","type":"article","venue":"JACC Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":139,"is_retracted":false,"has_abstract":true,"ca_institutions":"Canadian VIGOUR Centre; University of Alberta","funders":"Roche Diagnostics; Merck Sharp and Dohme; Servier; National Medical Research Council; Cytokinetics; Boston Scientific Corporation; Amgen; Boehringer Ingelheim; Medtronic; Roche; Novartis; Bayer; AstraZeneca; American Regent; Meso Scale Diagnostics; Sanofi; Merck; Vifor Pharma; Bristol-Myers Squibb Foundation","keywords":"Natriuretic peptide; Medicine; Heart failure; Hazard ratio; Internal medicine; Ejection fraction; Quartile; Clinical endpoint; Randomization; Confidence interval; Placebo; Cardiology; Clinical trial; Gastroenterology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003664579,0.0004048246,0.000737922,0.00020881,0.0001437696,0.0004008544,0.0003192441,0.0007398366,0.002375654],"category_scores_gemma":[0.005184556,0.0001563815,0.0006493615,0.0002006082,0.0003062918,0.0003429623,0.0002274613,0.0009990633,0.0001785328],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002315292,"about_ca_system_score_gemma":0.0004702462,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005137875,"about_ca_topic_score_gemma":0.0006299387,"domain_scores_codex":[0.9982417,0.001180568,0.00007320668,0.0002114626,0.0001643313,0.0001288115],"domain_scores_gemma":[0.9955188,0.002446771,0.001334694,0.0001924759,0.0001690304,0.000338207],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.3279986,0.003788338,0.5912672,0.001149719,0.005138657,0.000164937,0.0001317825,0.0009829621,0.00518626,0.0001938616,0.0008291913,0.06316842],"study_design_scores_gemma":[0.009409848,0.02543011,0.959524,0.00009472631,0.001844466,0.0002699621,0.00005296806,0.001127234,0.001227107,0.0002979824,0.0007005323,0.00002111595],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9935812,0.00506604,0.000227392,0.0002088392,0.00003956001,0.00005665153,0.0002690368,0.00000576563,0.00054557],"genre_scores_gemma":[0.9987826,0.0003675953,0.0002016434,0.0001025712,0.00007171779,0.00004816044,0.0001594831,0.000001541262,0.0002647465],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003664579,"threshold_uncertainty_score":0.01938039,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04419804845653504,"score_gpt":0.3421884006872881,"score_spread":0.2979903522307531,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}